![](/img/cover-not-exists.png)
Long‐term safety and efficacy of the sodium glucose cotransporter 2 inhibitor tofogliflozin added on glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus (J‐ STEP / GLP ): a 52‐week open‐label, multicenter, post‐marketing clinical study
Terauchi, Yasuo, Fujiwara, Hisataka, Kurihara, Yuji, Suganami, Hideki, Tamura, Masahiro, Senda, Masayuki, Gunji, Ryoji, Kaku, KoheiLanguage:
english
Journal:
Journal of Diabetes Investigation
DOI:
10.1111/jdi.13066
Date:
April, 2019
File:
PDF, 363 KB
english, 2019